Abstract Background Pyrazinamide (PZA) is an important component of first-line drugs because of its distinctive capability to kill subpopulations of persistent Mycobacterium tuberculosis (MTB). The prodrug (PZA) is converted to its active form, pyrazinoic acid (POA) by MTB pncA-encoded pyrazinamidase (PZase). Mutation in pncA is the most common and primary cause of PZA resistance. The aim of the present study was to explore the molecular characterization of PZA resistance in a Pashtun-dominated region of Khyber Pakhtunkhwa, Pakistan. Methods We performed drug susceptibility testing (DST) on 753 culture-positive isolates collected from the Provincial Tuberculosis Control Program Khyber Pakhtunkhwa using the BACTEC MGIT 960 PZA method. In add...
In clinical isolates of Mycobacterium tuberculosis (MTB), resistance to pyrazinamide occurs by mutat...
In clinical isolates of Mycobacterium tuberculosis (MTB), resistance to pyrazinamide occurs by mutat...
Tuberculosis (TB) is a highly infectious disease that causes the second highest mortality rate in hu...
Pyrazinamide (PZA) has been in use for almost 50 years as a first-line drug for short-course chemoth...
Abstract Background Detection of pyrazinamide (PZA) resistance in Mycobacterium tuberculosis (TB) pa...
Without the proper information on pyrazinamide (PZA) susceptibility of Mycobacterium tuberculosis (M...
ABSTRACT Pyrazinamide (PZA) is a prodrug that is converted to pyrazinoic acid by the enzyme pyrazina...
Pyrazinamide is one of the four first line drugs for treatment of tuberculosis. It has been widely a...
Abstract Background Pyrazinamide (PZA) plays a unique role in the treatment for multidrug-resistant ...
Pyrazinamide (PZA) is a key antibiotic in current anti-tuberculosis regimens. Although the WHO has s...
Abstract Background The ongoing epidemic of multidrug-resistant tuberculosis (MDR-TB) in Georgia hig...
International audiencePyrazinamide (PZA) is a key antibiotic in current anti-tuberculosis regimens. ...
International audiencePyrazinamide (PZA) is a key antibiotic in current anti-tuberculosis regimens. ...
International audiencePyrazinamide (PZA) is a key antibiotic in current anti-tuberculosis regimens. ...
This study was designed to investigate the presence of mutations in the pncA gene, minimum inhibitor...
In clinical isolates of Mycobacterium tuberculosis (MTB), resistance to pyrazinamide occurs by mutat...
In clinical isolates of Mycobacterium tuberculosis (MTB), resistance to pyrazinamide occurs by mutat...
Tuberculosis (TB) is a highly infectious disease that causes the second highest mortality rate in hu...
Pyrazinamide (PZA) has been in use for almost 50 years as a first-line drug for short-course chemoth...
Abstract Background Detection of pyrazinamide (PZA) resistance in Mycobacterium tuberculosis (TB) pa...
Without the proper information on pyrazinamide (PZA) susceptibility of Mycobacterium tuberculosis (M...
ABSTRACT Pyrazinamide (PZA) is a prodrug that is converted to pyrazinoic acid by the enzyme pyrazina...
Pyrazinamide is one of the four first line drugs for treatment of tuberculosis. It has been widely a...
Abstract Background Pyrazinamide (PZA) plays a unique role in the treatment for multidrug-resistant ...
Pyrazinamide (PZA) is a key antibiotic in current anti-tuberculosis regimens. Although the WHO has s...
Abstract Background The ongoing epidemic of multidrug-resistant tuberculosis (MDR-TB) in Georgia hig...
International audiencePyrazinamide (PZA) is a key antibiotic in current anti-tuberculosis regimens. ...
International audiencePyrazinamide (PZA) is a key antibiotic in current anti-tuberculosis regimens. ...
International audiencePyrazinamide (PZA) is a key antibiotic in current anti-tuberculosis regimens. ...
This study was designed to investigate the presence of mutations in the pncA gene, minimum inhibitor...
In clinical isolates of Mycobacterium tuberculosis (MTB), resistance to pyrazinamide occurs by mutat...
In clinical isolates of Mycobacterium tuberculosis (MTB), resistance to pyrazinamide occurs by mutat...
Tuberculosis (TB) is a highly infectious disease that causes the second highest mortality rate in hu...